Key result
Mitral valve repair in acute native mitral valve infective endocarditis resulted in 11% 30-day mortality and a 5.7% rate of recurrent endocarditis over a mean 10-month follow-up.
Why the study?
Mitral valve repair is technically challenging and not commonly performed in acute native mitral valve infective endocarditis.
Does mitral valve repair provide acceptable outcomes in patients with acute native mitral valve infective endocarditis?
Observational (n=35)
Does mitral valve repair provide acceptable outcomes in patients with acute native mitral valve infective endocarditis?
Mitral valve repair is a feasible treatment option for acute native mitral valve infective endocarditis, offering acceptable short-term results despite the complexity of the procedure.
No takes yet. Share an insight, caveat, or question.
MVR may be feasible in selected acute native MV IE; leaves open durability and comparative efficacy versus replacement.
Gabry et al. (2019) conducted an observational in acute native mitral valve infective endocarditis (n=35). Mitral valve repair was evaluated on successful MVR and freedom from recurrent endocarditis. Mitral valve repair in acute native mitral valve infective endocarditis resulted in 11% 30-day mortality and a 5.7% rate of recurrent endocarditis over a mean 10-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: